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doi:10.1016/j.pedneo.2011.03.013Premature babies experience pain and require adequate analgesia for any painful proce-
dure. Fentanyl and morphine resulted in safe and effective anesthesia in the past; however,
their pharmacokinetics may be impaired in preterm babies with multiorgan failure. Remifen-
tanil, despite the absence of available pharmacokinetic data in preterm infants and few
reports in newborns, demonstrated its advantages in children undergoing either major
surgery or minor painful procedures and has been shown to be useful even in neonates,
because its elimination is independent of organ function. We report two cases of babies born
at 26 weeks’ and 27 weeks’ gestation, weighing 580 g and 400 g, respectively, undergoing
laparotomy for necrotizing enterocolitis. Both received midazolam bolus and remifentanil
infusion at high doses. This technique seems to be an advantageous alternative even in
extremely low-birth-weight prematures. Furthermore, it becomes a technique of choice in
these babies because the available ventilators are often not equipped with halogenated
vaporizers. Particularly in intensive care, where there are no scavenger systems, it could
allow to operate without moving out the preterm babies and avoiding stress and
hypothermia.
Copyright ª 2011, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
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an Pediatric Association. Publish1. Introduction
It is now accepted that premature babies experience pain;
therefore, adequate analgesia should be provided for any
painful procedure.1 Anand and Sippell2 report that babiesed by Elsevier Taiwan LLC. All rights reserved.
Remifentanil in extremely low-birth-weight babies 177who undergo surgical procedures without effective anal-
gesia show a pronounced increase in stress hormone
concentrations, and these changes may adversely influence
outcome. Neonates are known to be relatively sensitive to
hypotension induced by volatile agents in comparison with
older children.3
It should be considered that very-low-birth-weight
premature babies are often ventilated by high-frequency
oscillatory ventilation (HFOV) to reduce barotrauma asso-
ciated with conventional ventilation.4 These ventilators are
not equipped with halogenated vaporizers, and total
intravenous anesthesia is mandatory.
Several opioid agents have been used for this purpose:
fentanyl anesthesia has been shown to be safe and effec-
tive, but the pharmacokinetics of this drug may be impaired
in premature babies with multiorgan failure.5 Morphine
alleviates prolonged pain, reduces behavioral and hormonal
stress responses, and improves ventilator synchrony and
sedation among ventilated preterm neonates.6 However, it
is unclear whether it provides adequate analgesia for the
acute pain caused by invasive procedures in ventilated
preterm neonates.
Remifentanil is widely used in children,7 but literature
shows limited reports in infants,8 shortage regarding
preterms,9 and no evidence in extremely low-birth-weight
(ELBW) infants. However, it may be a useful opioid for
preterm infants because its elimination is independent of
hepatic and renal functions. For this reason, it has been
used in neonatal intensive care unit (NICU) for brief
ophthalmic procedures10 and for long-term sedation in
preterms needing mechanical ventilation.11
Encouraged by these sporadic experiences and by its
unique pharmacokinetic and pharmacodynamic charac-
teristics, we decided to use this opioid for two very
small preterms undergoing surgery for necrotizing
enterocolitis.
We do believe that our cases are the youngest patients
reported until now, and for this reason, written informed
consent to publish these data was obtained from both
families. Because the survival of ELBW prematures, such as
the possibility for them to undergo surgery is always more
frequent, we expect this report to be helpful as an alter-
native anesthesia technique.Table 1 Hemodynamic (HR and MAP) and respiratory (SaO2 and
Cases Baseline Minutes of surgery
5’ 10’ 15’ 20’
First case
HR 142 125 135 138 140
MAP 34 30 31 31 33
SaO2 95 94 95 95 86
EtCO2 34 33 35 33 32
Second case
HR 138 127 136 143 140
MAP 27 26 25 26 28
SaO2 93 93 92 91 92
EtCO2 33 35 33 32 33
HRZ heart rate; MAPZmean arterial pressure; SaO2ZO2 percutane2. Case Report
2.1. Case 1
The baby was born by caesarean section at 26 weeks’
gestation, weighing 580 g. Immediately after birth, he was
intubated, admitted to NICU, and connected to mechanical
ventilator (Babylog 8000 ventilator; Dra¨ger, Lu¨beck,
Germany) in HFOV.
The following day, because of the diagnosis of entero-
colitis, he underwent laparotomy. Before leaving the NICU,
a dopamine infusion (4 mcg/kg/min) was started to control
the hypotension caused by the septic state. On arrival to
the operating theater, the baby was moved from the
incubator to the operating table, where a forced air
warming device (Bair Hugger, Augustine Medical Inc., Eden
Prairie, MN, USA) was previously prepared. During all the
procedures, HFOV parameters were as follows: mean
airway pressure, 10 cmH20; frequency, 8 Hz; amplitude,
70%; and FiO2, 0.25. In this way, we could obtain regular
respiratory pattern performed by O2 percutaneous satura-
tion (SaO2) between 88% and 96% and a value of final
expiratory CO2 (EtCO2) between 31 mmHg and 35 mmHg.
The hemodynamic and respiratory parameters are shown in
Table 1.
Midazolam 0.5 mg bolus was administered and remi-
fentanil infusion (RI) 0.25 mcg/kg/min was started and
increased in 15 minutes up to 3 mcg/kg/min. Because of
a desaturation episode (from 94% to 86%), FiO2 was
temporarily increased to 0.35, and the oxygen saturation
was restored to 95%. Then RI was increased step by step up
to 7.2 mcg/kg/min and was maintained during the entire
operation. After 30 minutes, the mean arterial pressure
decreased at 26 mmHg, and it was treated by increasing
dopamine infusion (6 mcg/kg/min) and by starting blood
administration (5 mL). As blood pressure was restored to
normal values, dopamine infusion was decreased to initial
rate (4 mcg/kg/min).
The surgery lasted for 1 hour, and no other episodes of
hypotension or desaturation were observed. In the last 15
minutes, RI was gradually decreased to 0.1 mcg/kg/min and
was maintained at the same rate until the baby was trans-
ferred back to the NICU. In the postoperative period, RI wasEtCO2) parameters
25’ 30’ 35’ 40’ 45’ 50’ 55’
150 151 149 147 145 148 149
32 26 28 33 36 34 34
95 93 95 96 94 95 94
34 28 29 30 32 33 32
135 132 133 135 134 137
27 26 25 26 27 28
90 88 90 91 93 92
33 32 34 31 34 33
ous saturation; EtCO2Z final expiratory CO2.
178 M. Sammartino et almaintained at 0.05-mcg/kg/min to 0.1-mcg/kg/min range
to achieve a good sedation for mechanical ventilation. The
condition of the baby was stable for the following week,
after which it was possible to extubate him.
2.2. Case 2
The baby was born by caesarian section at 27 weeks and 4
days’ gestation, weighing 340 g. Apgar at the first minute
was 3 and after 5 minutes was 8. He was intubated and
transferred to NICU where he was connected to a mechan-
ical ventilator (Babylog 8000 Plus). The heart rate was
140/min and SaO2 was 96%, with FiO2 of 0.21.
In the second day of life, epinephrine, red cells, and
frozen plasma were administered for a massive lung
hemorrhage. The following day, he was again hypotensive.
A chest X-ray was performed, and it showed severe bilat-
eral opacities: an improvement of SaO2 and a reduction of
FiO2 were achieved by surfactant therapy. Clinical condi-
tions became more stable. In the seventh day of life,
a distended abdomen was observed: an abdominal X-ray
confirmed the presence of air trapping. The baby was
receiving albumin, a total parenteral nutrition, so that at
the moment of surgery he weighed 400 g.
He was transferred to the operating theater with a remi-
fentanil sedation at 0.08-mcg/kg/min rate. HFOV parame-
ters were as follows: mean airway pressure, 8 cmH20;
frequency, 8e9 Hz; amplitude, 70%; and FiO2, 0.21.
For anesthesia induction, midazolam 0.4 mg was admin-
istered, and RI was increased up to 0.25 mcg/kg/min. During
the procedure, remifentanil rate achieved a maximum of
3 mcg/kg/min. Oxygen saturation remained stable ranging
between 88% and 93%, with FiO2 of 0.21. Hemodynamic
parameters were stable, and there was no evidence of
hypotension and tachycardia (Table 1). At the end of
surgery, RI was gradually decreased to 0.25 mcg/kg/min and
maintained until the baby was transferred to the NICU.
Surgery was well tolerated, as reported in the clinical chart
by neonatologists, but 3 days after surgery, the baby
developed severe metabolic acidosis and hypotension and
rapidly became decompensated. An immediate therapy
with bicarbonates, fluids, dopamine, and dobutamine was
started, but the following night, clear signs of shock were
observed, and the baby died as a result of cardiac collapsus.
3. Discussion
In our cases, it was not possible to use inhalation anesthesia.
In fact, in our NICU, HFOV is preferred to conventional
ventilation because of the protective role against baro-
trauma in ELBW, and this kind of ventilator does not allow
the use of halogenated agents. We chose to administer
a single bolus of midazolam for the induction of anesthesia.
Soriano and Anand12 have showed that prolonged adminis-
tration of anesthetic drugs, including midazolam, produces
increased neurodegeneration in 7-day-old rat pups.
Although these studies question the applicability of the data
to the anesthetic management of neonates,12 our patients
received a single high dose of midazolam to provide anes-
thesia and to avoid the use of muscle relaxants to monitor
the possible motor response to pain. Furthermore, severalstudies by Anand13 demonstrated that preterm babies build
up a substantial stress response to surgery if opioids are not
administered.
Consequently, infants undergoing anesthetics without
opioids develop clinical complications because of skeletal
muscle breakdown associated with weight loss and poor
clinical conditions. Preterm babies are not, as widely
accepted, capable of localizing pain because of the lack of
myelinization in the central nervous system and cannot
interpret it because they are not able to memorize previous
painful experiences. However, these studies noted a very
early pain perception mediated by brain regions (sensory
motor cortex, thalamus, and others) particularly involved
during painful procedures.14
As preterm infants have immature hepatic and renal
functions, variations in opioid metabolism may often occur.
Compared with both older children and adults, they have
a reduced clearance, an increased half-life, and a greater
volume of distribution.15 These variations in clearance and
elimination are likely because of the age-related matura-
tion of hepatic microsomial enzyme activity and/or the
age-related distribution of hepatic blood flow.16
In our two cases, classic opioid side effects, such as
bradycardia, rigidity, and severe hypotension, were not
observed. We did not modify the oscillatory ventilation
parameters except a transient modification of FiO2, and
hemodynamic stability was a witness of adequate anes-
thesia. Because it is not possible in ELBW infants to predict
the pharmacokinetics of other opioids, such as fentanyl and
morphine, the risk of side effects and inadequate anes-
thesia is high. Moreover, fentanyl can induce hypotension
not easily reversible. In this context, remifentanil appears
to be very useful as its unique pharmacokinetic profile
results in rapid metabolism by nonspecific plasma and
tissue esterases independent of hepatic and renal func-
tions15 and in fast offset.
As a potent opioid, it can be titrated to allow different
levels of sedation and analgesia or deep anesthesia.17
Because of the lack of validated monitoring devices, we
were obliged to titrate RI based on our previous experi-
ences10 and on hemodynamic responses.
In the present cases, we observed an intraoperative
hemodynamic stability using remifentanil at high doses. In
the first case, a mild transient hypotension was observed,
but it was not associated with bradycardia, and we assumed
that it did not depend on remifentanil dose.
According to its pharmacokinetics, the remifentanil
context-sensitive half-life does not vary with duration of
infusion. Clinical effects rapidly disappear on discontinua-
tion of the drug without prolonged recovery and long-
lasting ventilatory complications even in these delicate and
tiny patients.18 Considering the difficulties in performing
pharmacokinetic studies in such microprimies, clinical
reports are still the major source of knowledgeable infor-
mation in this issue.References
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